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Abstract: Recent advances in bioorthogonal catalysis are
increasing the capacity of researchers to manipulate the fate of
molecules in complex biological systems. A bioorthogonal
uncaging strategy is presented, which is triggered by heteroge-
neous gold catalysis and facilitates the activation of a structur-
ally diverse range of therapeutics in cancer cell culture.
Furthermore, this solid-supported catalytic system enabled
locally controlled release of a fluorescent dye into the brain of
a zebrafish for the first time, offering a novel way to modulate
the activity of bioorthogonal reagents in the most fragile and
complex organs.
Seminal works showcased the capabilities of foreign tran-
sition metal catalysts in mediated chemoselective transfor-
mations within cells.[1] More recently, the emerging field of
bioorthogonal catalysis[2] has produced a wealth of creativity
in a variety of applications, ranging from biomolecule label-
ing,[3a–c] metabolite detection[3d] and intra/subcellular probe
release,[3e–h] to in situ enzyme[3i,j] and prodrug activation.[3k–o]
Substoichiometric activity and access to a greater diversity of
chemical processes and functionalities are some of the added
benefits provided by abiotic transition metals to the current
bioorthogonal toolbox, thus expanding the boundaries of this
central field of research.[4] One of the latest additions to this
area was recently reported by Tanaka and coworkers,[5] who
developed a novel strategy for in vivo protein labeling
mediated by glycoalbumin-bound gold(III) complexes
(Scheme 1). Despite recent advances in the field, many
challenges lie ahead as transition metal catalysts show limited
biocompatibility in living systems in terms of catalytic
versatility and inherent toxicity.
Gold catalysis has received enormous attention in organic
synthesis over the last decades.[6] Among the chemical
properties of gold that stand out are its preference to
coordinate with alkynes in the presence of other functional
groups, including alkenes.[6, 7] Solid-supported gold nano-
particles (Au-NP) have also attracted the interest of chemists
searching for greener catalysts, because such catalysts are
recyclable, gold is safe to handle, and it demonstrates
a remarkable ability to catalytically mediate oxidative
reactions at or even below ambient temperatures.[7] In the
chemical biology field, however, the chemistry of gold is
dominated by near-covalent S@Au bonding.[8] This sponta-
neous bond formation provides the basis for the bottom-up
self-assembly of monolayers functionalized with a multitude
Scheme 1. a) AuIII-mediated bioorthogonal amidation reported by
Tanaka and coworkers.[5] b) The solid-supported gold-catalyzed uncag-
ing strategy developed in this work.
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of small molecules and biomolecules at the surface of the
metal—a highly reliable process that has found widespread
application in nanotechnology, biotechnology, and theranos-
tics.[8] Because of the high affinity of thiols for gold and their
ubiquitous presence in peptides and proteins, the attractive
alkynophile properties of Au-NP pass unnoticed in the
biological milieu. We envisioned that embedding Au-NP in
a solid support would serve to protect the metal nano-
structures from large thiol-rich biomolecules, while allowing
alkyne-functionalized small molecules to enter and undergo
gold-mediated chemistry even in biological systems. Impor-
tantly, based on the high biocompatibility of metallic gold,
such a device would be optimal to catalyze bioorthogonal
transformations in vivo. In a suitable shape and size, this
functional device could potentially be implanted by a surgeon
at the anatomical site of a localized cancer (for example, the
brain) and enable the local “manufacture” of different
drugs—in a catalytic fashion—from systemically adminis-
tered innocuous starting materials. This unique delivery
method would offer the benefits of drug release systems[9]
(that is, focal treatment and reduced general side effects) with
fewer limitations (for example, extended lifetime and access
to multiple therapies).
Towards this goal, herein we report the first example of
bond-cleavage chemistry mediated by heterogeneous gold
catalysts in living systems (Scheme 1)—a previously over-
looked chemical reactivity of gold that facilitates the efficient
bioorthogonal uncaging of various clinically approved anti-
cancer drugs in cancer cell culture and the first intracranial
activation of a bioorthogonal probe in zebrafish.
Solid-supported gold catalysts (Figure 1a,b) were pre-
pared by in situ generation of Au-NP within a polyethylene




75 microns in diameter (Rapp Polymere GmbH) were treated
with tetrachloroauric(III) acid and sodium hydroxide in
water:tetrahydrofuran (THF) followed by reduction with
tetrakis(hydroxymethyl)phosphonium chloride (THPC; see
full synthesis in the Supporting Information). THPC was used
to control particle growth and distribution because of its
relatively mild reducing properties.[10] High-angle annular
dark-field (HAADF) scanning transmission electron micro-
scopy (STEM) images of ultramicrotome cross-sections of the
resins showed uniformly dispersed polyhedral nanocrystals of
30 nm average diameter across the polymer framework
(Figure 1b; Supporting Information, Figure S1). X-ray photo-
electron spectroscopy (XPS, Supporting Information) analy-
sis detected an incremental gradient concentration of gold
from the surface to the core of the resins, with an Au0/Aud+
ratio ranging from 7 (periphery) to 19 (interior).
To investigate the properties of the [Au]-resins in
physiological conditions, the devices were incubated with
nonfluorescent compound 1, which releases strongly fluores-
cent Rhodamine 110 (2) upon O-depropargylation (Fig-
ure 1c). Reactions were performed in phosphate buffered
saline (PBS; pH 7.4) at 37 8C, either with or without serum,
and fluorescence was measured with a spectrophotometer.
Analysis revealed the rapid generation of fluorescence under
both conditions, with the presence of serum achieving a much
greater fluorogenic effect (ca. 25% yield), demonstrating the
feasibility of performing Au-NP-mediated chemistry beyond
the S@Au bonding in biocompatible environments. Time-
course and reusability studies (Supporting Information,
Figures S3 and S4) provided proof of the durability of the
Figure 1. a) Scanning electron microscopy (SEM) images of [Au]-resins. b) HAADF-STEM images of a cross-section of a [Au]-resin at different
magnifications and energy-dispersive X-ray (EDX) spectra of highlighted areas. c) Cleavage of N-Poc-protected prodye 1 (20 mm) in the presence
of [Au]-resins (1 mgmL@1) at physiological conditions (pH 7.4, 37 8C). Central panel: reaction kinetics in PBS or serum. Right panel: fluorescence
analysis at 24 h in different conditions. Negative control: reagent 1 without [Au]-resins.
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devices and their capacity to activate multiple doses of
masked reagent—although a gradual decay in activity was
observed over time.
To better understand the enhanced catalytic activity of the
[Au]-resins in the presence of serum, we investigated the
influence of OH, SH, and NH2 groups (nucleophilic groups
found in serum proteins) in the conversion of 1 into 2 by
adding excess ethylene glycol (3a), 2-mercaptoethanol (3 b),
and ethanolamine (3c), respectively. These low molecular
weight chemicals were used to facilitate diffusion throughout
the resins, thereby maximizing their interaction with internal
Au-NP. All the reactions were carried out in PBS at 37 8C.
Although 3a had a relatively minor effect on the catalytic
capacity of the devices, substantial variations in activity were
observed in the presence of 3b and 3c (Figure 1 c). Thiol 3b
suppressed the reactivity of the resins almost completely,
whereas addition of amine 3c boosted catalytic activity
significantly. The combined presence of an excess of both
3b and 3c resulted in low levels of fluorescence intensity. This
prompted us to investigate the influence of glutathione in the
reaction, a natural reductant that contains a SH and an NH2
group in its structure. Since glutathione is found ubiquitously
in the human plasma and the interstitial fluid at a concen-
tration of 2–20 mm,[11] we studied the reaction of 1 and [Au]-
resins at concentrations ranging from 10 to 400 mm. As shown
in the Supporting Information, Figure S5, increasing gluta-
thione levels up to 50 mm promoted the reaction, whereas
greater concentrations led to a substantial reduction in
fluorescence intensity. Notably, a large regain in catalytic
activity was achieved upon addition of an extra milligram of
[Au]-resins to the inhibited reactions. In contrast, if the
concentration of probe 1 was augmented, no significant
increase in fluorescence generation was observed. These
results indicate that S@Au bonding of glutathione molecules
on the surface of the Au-NP promote the dealkylation
reaction until a saturation threshold is reached (see rationale
in Scheme 2a). Over the saturation limit, gold-bound bio-
molecules will coat most active sites on the Au-NP surface,
thus hindering gold–alkyne coordination. A series of tests
carried out to monitor and analyze the reaction (Supporting
Information, Figures S6 and S7) corroborated that Rhod-
amine 2 was the main product of the reaction, along with
intermediates that could correspond to organogold species.
However, no reaction byproducts were isolated or identified,
which points to the production of short-lived compounds.
Based on these experimental observations, we tentatively
propose a dealkylation pathway whereby gold acts as a p-acid
to activate the nucleophilic addition of biomolecules onto the
terminal alkyne group, leading to release of the leaving group
(for example, a dye or drug) and the generation of reactive
allenyl byproducts (Scheme 2b) that isomerize or hydrolyze
under the reaction conditions.
Prior to testing the catalytic properties of the devices in
cell culture, viability assays (PrestoBlueU reagent) were
performed to determine the tolerance of cells to the presence
of solid-supported gold. As anticipated, [Au]-resins were
found to be fully biocompatible at the concentrations tested
(Supporting Information, Figure S8).
Subsequently, the bioorthogonal [Au]-triggered release of
a structurally diverse selection of clinically used anticancer
drugs was investigated in culture with human lung cancer
A549 cells. Three different drug precursors were tested (see
Figure 2a): Pro-FUdR [12a] (4a), POB-SAHA[12b] (4b), and
N-Poc-DOX (4 c ; a novel drug precursor inspired by prior
designs[3m, 13]). Cells were treated with 4a–c and [Au]-resins
separately (negative controls) or in combination (activation
assay), and unmodified drugs 5a–c used as the positive
controls. Remarkably, while prodrugs 4 a–c did not elicit any
effect on their own, potent anticancer activity was displayed
in combination with [Au]-resins (Figure 2a); unequivocal
evidence that the active drugs are released in situ by hetero-
geneous gold chemistry. Reuse of the [Au]-resins in three
consecutive prodrug activation cycles confirmed the capacity
of the devices to activate multiple drug doses (Supporting
Information, Figure S9). The synthesis of drugs 5 a–c was also
verified in vitro (Supporting Information, Figure S10), con-
firming the capability of gold to cleave both O- and
N-propargyl groups from a range of molecules based on
structurally different scaffolds. These studies support a poten-
tial application scenario where gold-functionalized implants
could be used in situ to modulate the spatiotemporal gen-
eration of chemotherapeutics from inactive precursors in the
treatment of localized malignancies such as brain or prostate
cancer.
Encouraged by the biocompatibility and catalytic proper-
ties of the [Au]-resins, we embarked on an innovative study to
evaluate the capacity of the devices to convert nonfluorescent
1 into Rhodamine 2 inside the cranium of zebrafish embryos.
Firstly, a single [Au]-resin was carefully transplanted into the
optic tectum, a small anatomical cavity[14] of the brain of
zebrafish larvae. After the surgery, either reagent 1 (activation
assay) or just dimethyl sulfoxide (DMSO; negative control)
were added to the medium and embryos imaged at 24 h (n =
5). Because of its lipophilicity, prodye 1 can enter the
zebrafish through the skin and/or by ingestion and distribute
systemically, but will only be converted into fluorescent
compound 2 upon reaction with the [Au]-bead. As shown in
Figure 2b, a strong green fluorescent signal originating from
Scheme 2. a) Rationale for the assisting–inhibiting roles of glutathione
in [Au]-catalyzed O/N-propargyl cleavage reactions. b) Tentative reac-
tion mechanism for the [Au]-triggered depropargylation of 1 and 4a–c
in the biological milieu.
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the [Au]-resin was observed only when incubated with 1,
confirming the local generation of Rhodamine 2. Prolonga-
tion of the study by three additional days corroborated
previous observations regarding the sustained functionality of
the devices (Supporting Information, Figure S11). This study,
which represents the first bioorthogonal organometallic
reaction to be locally performed in the brain of a living
animal, indicates that heterogeneous gold catalysts have the
capacity to mediate in vivo bioorthogonal release of func-
tional reagents in a spatially controlled manner.
In conclusion, we have developed a heterogeneous cata-
lytic system that enables access to chemical properties of
Au-NP that were previously out of our reach in biological
environments. Such devices triggered the bioorthogonal
uncaging of a structurally diverse selection of cytotoxic
precursors through an unexplored chemical reactivity of
gold, providing a novel and safe method to activate ther-
apeutics by nonbiological chemical stimuli.[3k–o, 13, 15] Further-
more, this solid-supported catalyst enabled—for the first
time—the locally controlled release of a fluorescent dye in the
brain of a zebrafish. This notable breakthrough expands our
capacity to chemically modulate the activity of bioorthogonal
reagents in the most fragile and complex organs.
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